VerifiedFact Checked
Why don't some people respond as well to GLP-1s?

Why don't some people respond as well to GLP-1s?

Like with any medication, people can respond to GLP-1s differently. Some are highly sensitive responders, meaning they respond really well even to lower doses, and may not need to move up doses at all.

Others, though, need to move to the highest dose to see the full (or any) results. And, unfortunately, for a smaller group, the medication doesn’t seem to work, even at the maximum dose. This lack of response can come down to a few different causes, including GLP-1 receptor resistance. 

Craig Marsh
Medically reviewed by
Craig Marsh, Independent Prescriber
Go to
Reviewed on Feb 18, 2026. by Mr Craig Marsh Independent Prescriber Registered with GPhC (No. 2070724) Next review due on Feb 18, 2029.
Craig

Last updated on Mar 10, 2026.

Was this article useful?
  • 9% to 27% of people don’t lose significant weight on GLP-1s like semaglutide (Wegovy) and tirzepatide (Mounjaro).
  • Genetics, metabolism, body composition, gut microbiomes, and receptor resistance can all make someone less likely to respond to GLP-1 therapy.
  • Genes can have a strong influence on your weight and eating behaviours, influencing appetite, hunger hormones, metabolism, and also how your body takes in and responds to GLP-1 therapy.
  • If your GLP-1 medication doesn’t work as well as expected, there are other options, like Orlistat and Mysimba, that might work better with your metabolism and genetic makeup.

What makes someone less likely to respond to GLP-1s?

It’s thought that around 9% to 27% of people don’t lose significant weight (defined as at least 5% of their initial body weight) after using GLP-1s like semaglutide (Wegovy) or tirzepatide (Mounjaro). So here’s why this might happen:

Variations in the GLP1R gene

This may sound a bit technical, but bear with us, it’s actually pretty straightforward. GLP-1s work by binding to receptors called GLP-1 receptors, which play a role in many processes in the body, including:

  • Regulating blood sugar levels
  • Slowing down how quickly food leaves the stomach
  • Reducing appetite
  • Supporting heart health
  • Improving cholesterol levels
  • Improving brain function
  • Reducing inflammation

These receptors are encoded in a tiny part of your DNA called the GLP1R gene. But this gene doesn’t look exactly the same for everyone. Some people have certain variations in it that can:

  • change how well GLP-1s bind to the GLP-1 receptors (and how well they work as a result)
  • affect some of the GLP-1 effects, like insulin secretion and how quickly the stomach empties (which can influence your blood sugar levels and appetite)
  • help explain why some people see better results from these medications than others

Baseline metabolism

Basal metabolic rate, or BMR, is the minimum number of calories or energy your body needs to perform vital functions like breathing, maintaining body temperature, and pumping blood.

As you lose weight with GLP-1s, your BMR may naturally decrease, as a smaller body usually needs fewer calories for sustenance. And because weight loss basically results from the difference between calories consumed and calories burned, and BMR makes up a large part of the calories you burn, a lower BMR can mean losing less weight. So this can be one reason why GLP-1s aren’t working as well for you.

You can learn more about how to speed up your metabolism, increase your BMR, and potentially tilt the scales in your favour here.

Metabolic age

Metabolic age is a comparison between your BMR and the average BMR of people in your age group. Basically, a lower metabolic age means that your body is running more efficiently than average, while a higher metabolic age means your metabolism is a bit slower than the average for your age.

Similarly to BMR, having a higher metabolic age, aka slower metabolism, can make weight loss a bit harder because your body burns fewer calories at rest.

Don’t think that it’s all doom and gloom, though. GLP-1s like Wegovy can also help your body age better by supporting your energy levels, mobility, and sleeping patterns.

Body composition

When you lose weight, not all of it comes from fat. Up to 40% can come from lean mass, which includes muscle, water, and organ tissue. This is really important because muscle is the body’s most metabolically active tissue. So having less muscle typically means lower BMR, which again can mean that GLP-1s are less effective (we’ve covered this in more detail earlier under Baseline metabolism).

Ways in which you can combat this and get better results with GLP-1s include increasing your protein intake to around 1.2–1.6 g per kilogram of body weight per day and doing resistance training.

Microbiome composition

Studies on twins show that less diverse bacteria in the gut microbiome can increase the risk of obesity. GLP-1 medications can change the composition and diversity of gut bacteria, suggesting that part of how these drugs work might involve beneficial shifts in your microbiome.

Some clinical evidence suggests that people who respond well to GLP‑1 therapy have different gut microbiomes compared with non‑responders. For example, liraglutide (a GLP-1 medication) was associated with an increase in beneficial bacteria like Lactobacillus, Bacteroides, and A. muciniphila, while other bacteria were more common in poorer responders.

This opens up the possibility that, in the future, we can develop strategies to improve the effectiveness of these medications by targeting specific changes in the microbiome itself through diet, prebiotics, or probiotics.

What are the signs of receptor resistance?

We’ve already mentioned that GLP-1s need to bind to GLP-1 receptors to do their job. With receptor resistance, the GLP-1 medication is trying to send the right message, but the receptors just don’t (or can’t) ‘pick it up’ correctly. Consequently, all the effects you’d expect, like insulin release, slower digestion, and feeling fuller, don’t happen. And, as a result, the body’s response to the medication can be weaker than expected.

Receptor resistance can happen for a few reasons. It could be due to: 

  • genetics, meaning that your receptors are naturally less responsive,
  • problems in the way signals are passed along inside your cells,
  • or from overuse, which can make the receptor less receptive over time.

So, if you think that the jabs don’t really cut it for you, here’s how to tell if it’s time to review your treatment plan:

Persistent food noise

When they work as they should, GLP-1 injections slow down how fast your stomach empties and reduce appetite, which means they can dampen compulsive thoughts about eating, sometimes referred to as ‘food noise’. But if you still feel that constant, nagging food noise, even after moving up doses, this may be a sign that your body is experiencing receptor resistance.

Weight loss plateaus (even on the highest dose)

Hitting a weight loss plateau is probably one of the most frustrating experiences with GLP-1s, especially when it happens after you’ve already reached the maximum dose. If you’re doing everything ‘by the book’, but still don’t see the results on the scale, it’s likely due to receptor resistance.

Blood sugar levels do not budge

Initially, GLP-1 injections like semaglutide (the active ingredient in Wegovy) were developed to help with type 2 diabetes by controlling blood sugar. So if your blood sugar levels don’t change, especially if your weight is also plateauing, it could be a sign that the medication isn’t working as well as it should.

How do genetics play a role in sensitivity or resistance to weight loss injections?

To put it simply, genes don’t determine your weight, but they have a strong influence on:

  • how hungry you feel and how your brain and gut ‘talk’ to each other,
  • where your body holds on to weight,
  • how fast your metabolism is, and:
  • why people may respond differently to medications like GLP-1s.

A few theories that researchers are investigating that could explain the role played by genetics include:

Hungry brain vs. hungry gut

This theory suggests that, due to differences in genetic makeup, people experience appetite differently. For some people, it’s driven more by cravings, and thus the neurological component is more dominant. These are the people who are more ‘hungry in the brain’. For others, the hunger signals originate more from the gut and are due to hormonal responses, so these people are more ‘hungry in the gut’.

People who are ‘hungry in the brain’ tend to eat very large meals, while those who are ‘hungry in the gut’ tend to snack more frequently, but usually eat normal portions.
A recent study has found that GLP-1s tended to work better for those with a ‘hungry gut’.

The biological ‘set point’ for weight

Scientists think there’s some sort of a biological ‘set point’, meaning a weight range your body defends as its preferred weight. So, for example, if you lose weight, your body will increase your hunger hormones and lower your BMR to push your weight back up towards the ‘set point’. This ‘set point’ can be influenced by many things, like genetics, hormones like leptin and ghrelin, and past weight history, and it can change throughout a person’s life.

This could explain at least in part why weight loss can cause your appetite to increase and metabolism to slow down after a period of weight loss, making it difficult to maintain your weight long-term.

Genetics and appetite, metabolism, and hormones

Genetics can influence your metabolism and hormone levels to affect how easily you lose or maintain weight and how you respond to weight loss medication:

  • Twin and family studies show a strong hereditary component to body weight and BMR, suggesting that genetics can cause some people to have an ‘energy-sparing’ metabolism that makes them prone to obesity.
  • Genetics also influence appetite‑regulating hormones like leptin and ghrelin, which regulate hunger, satiety, and energy balance, and therefore eating behaviour.
Genetics and drug metabolism

Many genes can influence your metabolism and overall response to weight-loss medications, but here are some of the main culprits science has uncovered so far:

  • GLP1R: This gene encodes the GLP-1 receptor, and variations in it have been linked to play a role in the response to GLP-1 receptor agonists.
  • TCF7L2: Variants in this gene can affect how the natural hormone GLP-1 works in the body, potentially altering how the body responds to GLP‑1 therapy (which mimics the natural hormone).
  • KCNJ11 and KCNQ1: They regulate insulin secretion and how hormones like GLP-1 work in the body. Variations in them have been linked to differences in response to diabetes medications like GLP-1s.

What can be done if you think you may have receptor resistance?

If what we’ve talked about when it comes to receptor resistance applies to you, there are a few strategies that might help:

  1. Consider switching medications: It could be useful to try switching from Wegovy, which only acts on one type of receptor (GLP-1), to Mounjaro, which targets two receptors (GLP-1 and GIP). Mounjaro has also been shown to be more effective than Wegovy in clinical trials. And, in the future, when it becomes available, Retatrutide could be another option, as it also targets multiple receptors to help improve appetite, blood sugar, and weight loss.
  2. Eat a high-protein diet: This may help your body produce more of its own natural GLP‑1 hormone. Foods that contain dietary peptides like yoghurt, eggs, or lean meats stimulate GLP‑1 release and may support receptor activity, potentially improving how your body responds to the medication. Additionally, protein can help increase your BMR, which can also make a difference on the scales.
  3. Try changing meal times: Natural secretion of GLP‑1 hormones follows your circadian rhythm, meaning they work best during the day. So spreading your meals throughout daylight hours can help make GLP‑1 therapy more effective.

But keep in mind that these strategies aren’t guaranteed to overcome receptor resistance. They can, however, help maximise the effects of your treatment and keep your body healthy.

How do I know if it’s receptor resistance, or just that I need to move up a dose?

So your GLP‑1 jab isn’t working as expected, but you’re not sure if it’s receptor resistance or your dose needs adjusting. This is what you could look at:

  1. Side effects and appetite suppression disappear: If you no longer experience side effects like nausea and vomiting and appetite suppression, but you used to, your body is used to the current dose, and you can usually move up (if your clinician gives you the thumbs up).
  2. Side effects persist, but appetite suppression never occurred: If you still have side effects but have never experienced appetite suppression, then it’s likely you are resistant to the medication.
  3. Appetite suppression patterns during the week: If the medication doesn’t work to suppress your appetite at any point during the week, this is more likely to be resistance, but if the medication works in the first couple of days after you take the jab, and then wears off at day 3 or 4, this is a sign to move up a dose.
  4. Short plateaus: If you’re experiencing a short weight loss plateau for a couple of weeks, this is likely because you need to move up a dose.

What are the other options?

Whether it’s due to resistance or other factors, if your GLP‑1 jab isn’t giving you the results you want, there are other medications you can try. Two common options are Orlistat and Mysimba.

Orlistat

Orlistat works by blocking a portion of the fat you consume from being absorbed by your body, so that you actually take in fewer calories. It can help with weight loss when paired with a reduced‑calorie diet and exercise. Because it has a different mode of action compared to GLP-1 therapy, it can be effective if GLP-1s haven’t worked for you. Just like any other medication, it can cause side effects, some of them including oily stools or gas, but these are usually mild and often improve with a few adjustments in your diet.

Mysimba (bupropion + naltrexone)

Mysimba combines two active ingredients that work on the brain’s reward system to help reduce appetite and food cravings, and can help you feel less driven to overeating or snacking. Some people notice side effects like nausea or headaches when they start treatment, but these usually settle with time.

Bottom line

If you don’t respond well to GLP-1s, even though you’ve been following a calorie-deficit diet and exercising regularly, it could be due to genes, a slower metabolism, body composition, or gut bacteria. In most cases, there are strategies you can use to improve your chances of losing the extra weight (which we’ve mentioned above).

But if you think you’ve tried everything, and your weight just won’t budge on GLP-1s, other medications may help. Working closely with a clinician is the best way to find the safest and most effective approach for you. Some people respond better to medications that act on appetite (like Mysimba), while others benefit from medications that reduce calorie absorption (like Orlistat).

Reference Popover #ref1
Reference Popover #ref2
Reference Popover #ref3
Reference Popover #ref4
Reference Popover #ref5
Reference Popover #ref6
Reference Popover #ref7
Reference Popover #ref8
Reference Popover #ref9
Reference Popover #ref10
Reference Popover #ref11
Reference Popover #ref12
Reference Popover #ref13
Reference Popover #ref14
Reference Popover #ref15
Reference Popover #ref16
Reference Popover #ref17

How we source info.

When we present you with stats, data, opinion or a consensus, we’ll tell you where this came from. And we’ll only present data as clinically reliable if it’s come from a reputable source, such as a state or government-funded health body, a peer-reviewed medical journal, or a recognised analytics or data body. Read more in our editorial policy.

Tell us what you want to hear.

Have a subject you’d like us to cover in a future article? Let us know.

Give us the inbox treatment.

We're making healthcare more about you. Sign up to our newsletter for personalised health articles that make a difference.

Disclaimer: The information provided on this page is not a substitute for professional medical advice, diagnosis, or treatment. If you have any questions or concerns about your health, please talk to a doctor.